Teleflex Incorporated (TFX)

Currency in USD
118.41
+2.92(+2.53%)
Closed·
After Hours
118.69+0.28(+0.24%)
·
TFX Scorecard
Full Analysis
Management has been aggressively buying back shares
TFX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
117.01119.81
52 wk Range
108.90249.91
Key Statistics
Prev. Close
115.49
Open
117.24
Day's Range
117.01-119.81
52 wk Range
108.9-249.91
Volume
701.19K
Average Volume (3m)
528.28K
1-Year Change
-48.52%
Book Value / Share
96.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TFX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
140.11
Upside
+18.33%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Teleflex Incorporated News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Teleflex Incorporated Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated SWOT Analysis


Financial Resilience
Teleflex demonstrates adaptability amidst challenges, adjusting guidance while maintaining profitability through effective cost management and strategic initiatives
Market Dynamics
Explore Teleflex's navigation of complex market forces, from unexpected customer losses to promising growth in key segments like Intra-Aortic Balloon Pumps
Strategic Vision
Delve into Teleflex's growth strategy, combining organic expansion with strategic acquisitions to strengthen market position and drive innovation
Analyst Outlook
Price targets range from $210 to $285, reflecting varied optimism about Teleflex's future prospects and ability to overcome current headwinds
Read full SWOT analysis

Teleflex Incorporated Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of $3.73 beat forecasts by 11.01%, revenue reached $780.9M, exceeding expectations and driving stock up 7.05% in regular trading
  • Acquisition of Vascular Intervention business from BioTronic expected to boost revenues, generating over $800M annually from 2026
  • Company forecasts 7.7-8.7% constant currency revenue growth for 2025, with adjusted EPS between $13.90 and $14.30
  • Cash flow from operations declined to $81.2M from $204.5M, noted as potential concern amid overall positive financial performance
  • Management considering sale or spin-off of NewCo, evaluating options to maximize shareholder value
Last Updated: 31/07/2025, 15:20
Read Full Transcript

Compare TFX to Peers and Sector

Metrics to compare
TFX
Peers
Sector
Relationship
P/E Ratio
27.3x36.2x−0.5x
PEG Ratio
−1.09−0.850.00
Price/Book
1.2x4.2x2.6x
Price / LTM Sales
1.7x6.4x3.3x
Upside (Analyst Target)
14.0%45.3%43.5%
Fair Value Upside
Unlock−3.5%6.8%Unlock

Analyst Ratings

2 Buy
10 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 140.11
(+18.33% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.19%
Dividend Yield
1.15%
Industry Median 1.34%
Annualised payout
1.36
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
3.73 / 3.36
Revenue / Forecast
780.88M / 771.52M
EPS Revisions
Last 90 days

TFX Income Statement

People Also Watch

25.59
CNC
+1.31%
54.99
ATKR
0.00%
179.86
IQV
+0.51%
88.09
QRVO
+0.62%
250.89
UNH
+2.54%

FAQ

What Stock Exchange Does Teleflex Trade On?

Teleflex is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Teleflex?

The stock symbol for Teleflex is "TFX."

What Is the Teleflex Market Cap?

As of today, Teleflex market cap is 5.23B.

What Is Teleflex's Earnings Per Share (TTM)?

The Teleflex EPS (TTM) is 4.19.

When Is the Next Teleflex Earnings Date?

Teleflex will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is TFX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Teleflex Stock Split?

Teleflex has split 12 times.

How Many Employees Does Teleflex Have?

Teleflex has 14100 employees.

What is the current trading status of Teleflex (TFX)?

As of 09 Aug 2025, Teleflex (TFX) is trading at a price of 118.41, with a previous close of 115.49. The stock has fluctuated within a day range of 117.01 to 119.81, while its 52-week range spans from 108.90 to 249.91.

What Is Teleflex (TFX) Price Target According to Analysts?

The average 12-month price target for Teleflex is USD140.11111, with a high estimate of USD200 and a low estimate of USD120. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +18.33% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.